Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174432 | SCV000225731 | uncertain significance | not provided | 2014-09-08 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002485125 | SCV002776877 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-11-15 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000174432 | SCV003819728 | uncertain significance | not provided | 2022-07-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000174432 | SCV000237076 | not provided | not provided | 2013-06-03 | no assertion provided | clinical testing | Missense variants in the TTN gene are considered 'unclassified' if they are not previously reported in the literature and do not have >1% frequency in the population to be considered a polymorphism. Research indicates that truncating mutations in the TTN gene are expected to account for approximately 25% of familial and 18% of sporadic idiopathic DCM; however, truncating variants in the TTN gene have been reported in approximately 3% of reported control alleles. There has been little investigation into non-truncating variants. (Herman D et al. Truncations of titin causing dilated cardiomyopathy. N Eng J Med 366:619-628, 2012) The variant is found in DCM panel(s). |